Axial length measurement; a clinical necessity?

Six questions on axial length measurement in myopia management

This review covers how well axial length relates to refraction and predicting future myopia, how to measure axial length, its value in orthokeratology and atropine management, how axial length influences a treatment plan and can you practice myopia management without it.

Race as a predictor of myopia progression in paediatric patients

Myopia has multi-factorial causes with both nature and nurture contributing. In this research the authors used a retrospective cohort study to examine any differences in progression rate with different ethnicities and greater understand who may be at increased risk of myopic progression.

Patient progressing after treatment withdraw therapy myopia worse

Myopia Rebound: Back with a Vengeance

You may be ready to cease treatment, or the patient has done so of their own accord. Then you observe that the rate of myopic progression accelerates again – a myopia rebound effect. When does this happen? Can you avoid it? What should you consider doing in practice?

Scleral cross-linking using Rose Bengal green light

In myopia development the sclera is at risk of deformation due to increasing axial length progression. This research investigates whether cross-linking treatment could be used to stiffen the sclera as a way to restrict axial eye elongation.

Which atropine dosage should I prescribe for myopia control?

The research information on using atropine for myopia control is evolving. Previous research indicated 0.01% atropine was best, but newer research says otherwise. In this clinical case, practitioners discuss treatment strategies, which are put in research context with clinical pearls for practice.

When to prescribe Atropine for myopia control

Atropine can be used for myopia control as a monotherapy or as an adjunct to an optical intervention – we discuss patient selection, atropine combination treatments, how to taper and when to stop.

Adult Myopia Progression

Adult Myopia Progression, and how to treat it

Adult myopia progression is frequently encountered in practice, yet we have almost no evidence base to guide management. Here we explore how often and how much myopia progression occurs in adulthood, and management options.

When to stop myopia control treatments

When to stop Myopia Control Treatments

Myopia control treatments can be tapered or stopped when it appears myopia progression is stabilizing.When should you stop myopia control treatments?

Does pregnancy influence myopia?

HWN presented this case involving a 32-year-old woman whose myopia onset after having her first child and had progressed since.

Thinking beyond myopia – managing the very high childhood myope

Children with more than 5-6D of myopia can require special consideration to ensure safe management of their ocular and systemic health. This clinical case details important aspects of care for the very high childhood myope: ophthalmology co-management, best optical corrections, parental education and eye health monitoring.